Isophosphoramide Mustard - A Phase 1 Study

Morgan, Lee Roy

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Small Business Innovation Research Grants (SBIR) - Phase II (R44)
• Project #: 4R44CA083552-02
• Application #: 6211058
• Study Section: Special Emphasis Panel (ZRG1-SSS-1 (02))
• Program Officer: Wu, Roy S
• Project Start: 1999-08-04
• Project End: 2002-01-31
• Budget Start: 2000-02-21
• Budget End: 2001-01-31
• Support Year: 2
• Fiscal Year: 2000
• Total Cost: $225,894

Institution

• Name: Dekk-Tec, Inc.
• City: New Orleans
• State: LA
• Country: United States
• Zip Code: 70124

Publications

Germann, N; Urien, S; Rodgers, Andrew H et al. (2005) Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamide. Cancer Chemother Pharmacol 55:143-51